{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:40:42Z","timestamp":1793364042768,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1093"],"award-info":[{"award-number":["SFB 1093"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"North Carolina State Grant","award":["117250"],"award-info":[{"award-number":["117250"]}]},{"name":"Projekt DEAL"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The blood\u2013brain barrier (BBB) is an efficient barrier for molecules and drugs. Multicellular 3D spheroids display reproducible BBB features and functions. The spheroids used here were composed of six brain cell types: Astrocytes, pericytes, endothelial cells, microglia cells, oligodendrocytes, and neurons. They form an in vitro BBB that regulates the transport of compounds into the spheroid. The penetration of fluorescent ultrasmall gold nanoparticles (core diameter 2\u00a0nm; hydrodynamic diameter 3\u20134\u00a0nm) across the BBB was studied as a function of time by confocal laser scanning microscopy, with the dissolved fluorescent dye (FAM-alkyne) as a control. The nanoparticles readily entered the interior of the spheroid, whereas the dissolved dye alone did not penetrate the BBB. We present a model that is based on a time-dependent opening of the BBB for nanoparticles, followed by a rapid diffusion into the center of the spheroid. After the spheroids underwent hypoxia (0.1% O\n                    <jats:sub>2<\/jats:sub>\n                    ; 24\u00a0h), the BBB was more permeable, permitting the uptake of more nanoparticles and also of dissolved dye molecules. Together with our previous observations that such nanoparticles can easily enter cells and even the cell nucleus, these data provide evidence that ultrasmall nanoparticle can cross the blood brain barrier.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-75125-2","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T06:03:14Z","timestamp":1603346594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":106,"title":["Transport of ultrasmall gold nanoparticles (2\u00a0nm) across the blood\u2013brain barrier in a six-cell brain spheroid model"],"prefix":"10.1038","volume":"10","author":[{"given":"Viktoriya","family":"Sokolova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gehad","family":"Mekky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina Beatrice","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Seeds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Atala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Epple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,22]]},"reference":[{"key":"75125_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature12517","volume":"501","author":"MA Lancaster","year":"2013","unstructured":"Lancaster, M. A. et al. Cerebral organoids model human brain development and microcephaly. Nature 501, 373\u2013379 (2013).","journal-title":"Nature"},{"key":"75125_CR2","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/srep01500","volume":"3","author":"E Urich","year":"2013","unstructured":"Urich, E. et al. Multicellular self-assembled spheroidal model of the blood brain barrier. Sci. Rep. 3, 1500 (2013).","journal-title":"Sci. Rep."},{"key":"75125_CR3","doi-asserted-by":"publisher","first-page":"15222","DOI":"10.1038\/srep15222","volume":"5","author":"H Cho","year":"2015","unstructured":"Cho, H. et al. Three-dimensional blood-brain barrier model for in vitro studies of neurovascular pathology. Sci. Rep. 5, 15222 (2015).","journal-title":"Sci. Rep."},{"key":"75125_CR4","doi-asserted-by":"publisher","first-page":"e1129476","DOI":"10.1080\/21688370.2015.1129476","volume":"4","author":"PK Pandey","year":"2015","unstructured":"Pandey, P. K., Sharma, A. K. & Gupta, U. Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking. Tissue Barr. 4, e1129476 (2015).","journal-title":"Tissue Barr."},{"key":"75125_CR5","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1177\/0271678X16630991","volume":"36","author":"HC Helms","year":"2016","unstructured":"Helms, H. C. et al. In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use. J. Cereb. Blood Flow Metab. 36, 862\u2013890 (2016).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"75125_CR6","doi-asserted-by":"publisher","first-page":"15623","DOI":"10.1038\/ncomms15623","volume":"8","author":"CF Cho","year":"2017","unstructured":"Cho, C. F. et al. Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents. Nat. Commun. 8, 15623 (2017).","journal-title":"Nat. Commun."},{"key":"75125_CR7","doi-asserted-by":"publisher","first-page":"e1702858","DOI":"10.1002\/smll.201702858","volume":"14","author":"H Lu","year":"2018","unstructured":"Lu, H. & Stenzel, M. H. Multicellular tumor spheroids (MCTS) as a 3D in vitro evaluation tool of nanoparticles. Small 14, e1702858 (2018).","journal-title":"Small"},{"key":"75125_CR8","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.1038\/s41598-018-25603-5","volume":"8","author":"G Nzou","year":"2018","unstructured":"Nzou, G. et al. Human cortex spheroid with a functional blood brain barrier for high-throughput neurotoxicity screening and disease modeling. Sci. Rep. 8, 7413 (2018).","journal-title":"Sci. Rep."},{"key":"75125_CR9","doi-asserted-by":"publisher","first-page":"021","DOI":"10.24966\/AND-9608\/100021","volume":"5","author":"G Nzou","year":"2019","unstructured":"Nzou, G., Seeds, M. C., Wicks, R. T. & Atala, A. J. Fundamental neurovascular components for the development of complex and dynamic in vitro brain equivalent models. J. Alzheimers Neurodegener. Dis. 5, 021 (2019).","journal-title":"J. Alzheimers Neurodegener. Dis."},{"key":"75125_CR10","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1038\/s41596-018-0066-x","volume":"13","author":"S Bergmann","year":"2018","unstructured":"Bergmann, S. et al. Blood\u2013brain-barrier organoids for investigating the permeability of CNS therapeutics. Nat. Protoc. 13, 2827\u20132843 (2018).","journal-title":"Nat. Protoc."},{"key":"75125_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12989-019-0307-3","author":"PEC Leite","year":"2019","unstructured":"Leite, P. E. C. et al. Suitability of 3D human brain spheroid models to distinguish toxic effects of gold and poly-lactic acid nanoparticles to assess biocompatibility for brain drug delivery. Part. Fibre Toxicol. https:\/\/doi.org\/10.1186\/s12989-019-0307-3 (2019).","journal-title":"Part. Fibre Toxicol."},{"key":"75125_CR12","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.drudis.2016.06.024","volume":"21","author":"M Chatzinikolaidou","year":"2016","unstructured":"Chatzinikolaidou, M. Cell spheroids: The new frontiers in in vitro models for cancer drug validation. Drug Discov. Today 21, 1554\u20131560 (2016).","journal-title":"Drug Discov. Today"},{"key":"75125_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","volume":"235","author":"C Saraiva","year":"2016","unstructured":"Saraiva, C. et al. Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. J. Control. Rel. 235, 34\u201347 (2016).","journal-title":"J. Control. Rel."},{"key":"75125_CR14","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1039\/C3NR04878K","volume":"6","author":"M Shilo","year":"2014","unstructured":"Shilo, M., Motiei, M., Hana, P. & Popovtzer, R. Transport of nanoparticles through the blood-brain barrier for imaging and therapeutic applications. Nanoscale 6, 2146\u20132152 (2014).","journal-title":"Nanoscale"},{"key":"75125_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/pharmaceutics10040269","volume":"10","author":"DM Teleanu","year":"2018","unstructured":"Teleanu, D. M., Chircov, C., Grumezescu, A. M., Volceanov, A. & Teleanu, R. I. Blood-brain delivery methods using nanotechnology. Pharmaceutics 10, 269 (2018).","journal-title":"Pharmaceutics"},{"key":"75125_CR16","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1007\/s00204-015-1594-6","volume":"89","author":"X Zhang","year":"2015","unstructured":"Zhang, X., Li, W. & Yang, Z. Toxicology of nanosized titanium dioxide: An update. Arch. Toxicol. 89, 2207\u20132217 (2015).","journal-title":"Arch. Toxicol."},{"key":"75125_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/187152712799960817","volume":"11","author":"HS Sharma","year":"2012","unstructured":"Sharma, H. S. & Sharma, A. Neurotoxicity of engineered nanoparticles from metals. CNS Neurol. Disord. Drug Targets 11, 65\u201380 (2012).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"75125_CR18","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.3390\/ijms12096267","volume":"12","author":"TT Win-Shwe","year":"2011","unstructured":"Win-Shwe, T. T. & Fujimaki, H. Nanoparticles and neurotoxicity. Int. J. Mol. Sci. 12, 6267\u20136280 (2011).","journal-title":"Int. J. Mol. Sci."},{"key":"75125_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2018.07.036","volume":"77","author":"M Epple","year":"2018","unstructured":"Epple, M. Review of potential health risks associated with nanoscopic calcium phosphate. Acta Biomater. 77, 1\u201314 (2018).","journal-title":"Acta Biomater."},{"key":"75125_CR20","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1021\/acsnano.6b06040","volume":"11","author":"B Pelaz","year":"2017","unstructured":"Pelaz, B. et al. Diverse applications of nanomedicine. ACS Nano 11, 2313\u20132381 (2017).","journal-title":"ACS Nano"},{"key":"75125_CR21","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.cej.2019.05.055","volume":"373","author":"YJ Lu","year":"2019","unstructured":"Lu, Y. J. et al. Thermosensitive magnetic liposomes for alternating magnetic field-inducible drug delivery in dual targeted brain tumor chemotherapy. Chem. Eng. J. 373, 720\u2013733 (2019).","journal-title":"Chem. Eng. J."},{"key":"75125_CR22","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1021\/ar300031y","volume":"46","author":"MT Zhu","year":"2013","unstructured":"Zhu, M. T. et al. Physicochemical properties determine nanomaterial cellular uptake, transport, and fate. Acc. Chem. Res. 46, 622\u2013631 (2013).","journal-title":"Acc. Chem. Res."},{"key":"75125_CR23","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/15287390903489422","volume":"73","author":"EK Rushton","year":"2010","unstructured":"Rushton, E. K. et al. Concept of assessing nanoparticle hazards considering nanoparticle dosemetric and chemical\/biological responsemetrics. J. Toxicol. Environ. Health A 73, 445\u2013461 (2010).","journal-title":"J. Toxicol. Environ. Health A"},{"key":"75125_CR24","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1007\/s00204-017-2016-8","volume":"91","author":"G Schmid","year":"2017","unstructured":"Schmid, G., Kreyling, W. G. & Simon, U. Toxic effects and biodistribution of ultrasmall gold nanoparticles. Arch. Toxicol. 91, 3011\u20133037 (2017).","journal-title":"Arch. Toxicol."},{"key":"75125_CR25","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1039\/C9NH00628A","volume":"5","author":"E Darrigues","year":"2020","unstructured":"Darrigues, E. et al. 3D cultures for modeling nanomaterial-based photothermal therapy. Nanoscale Horiz. 5, 400\u2013430 (2020).","journal-title":"Nanoscale Horiz."},{"key":"75125_CR26","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.3390\/ijms19071993","volume":"19","author":"U De Simone","year":"2018","unstructured":"De Simone, U. et al. Human 3D cultures as models for evaluating magnetic nanoparticle cns cytotoxicity after short- and repeated long-term exposure. Int. J. Mol. Sci. 19, 1993 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"75125_CR27","doi-asserted-by":"publisher","first-page":"21227","DOI":"10.1039\/C9NR07976A","volume":"11","author":"A Marino","year":"2019","unstructured":"Marino, A. et al. Multifunctional temozolomide-loaded lipid superparamagnetic nanovectors: Dual targeting and disintegration of glioblastoma spheroids by synergic chemotherapy and hyperthermia treatment. Nanoscale 11, 21227\u201321248 (2019).","journal-title":"Nanoscale"},{"key":"75125_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.actbio.2020.04.023","volume":"111","author":"V Sokolova","year":"2020","unstructured":"Sokolova, V. et al. Ultrasmall gold nanoparticles (2 nm) can penetrate and enter cell nuclei in an in-vitro brain spheroid model. Acta Biomater. 111, 349\u2013362 (2020).","journal-title":"Acta Biomater."},{"key":"75125_CR29","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.nano.2016.02.019","volume":"12","author":"K Zarschler","year":"2016","unstructured":"Zarschler, K. et al. Ultrasmall inorganic nanoparticles: State-of-the-art and perspectives for biomedical applications. Nanomedicine 12, 1663\u20131701 (2016).","journal-title":"Nanomedicine"},{"key":"75125_CR30","doi-asserted-by":"publisher","first-page":"7191","DOI":"10.1021\/acs.langmuir.9b00295","volume":"35","author":"SB van der Meer","year":"2019","unstructured":"van der Meer, S. B. et al. Click chemistry on the surface of ultrasmall gold nanoparticles (2 nm) for covalent ligand attachment followed by NMR spectroscopy. Langmuir 35, 7191\u20137204 (2019).","journal-title":"Langmuir"},{"key":"75125_CR31","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.1021\/nn5018523","volume":"8","author":"M Bramini","year":"2014","unstructured":"Bramini, M. et al. Imaging approach to mechanistic study of nanoparticle interactions with the blood-brain barrier. ACS Nano 8, 4304\u20134312 (2014).","journal-title":"ACS Nano"},{"key":"75125_CR32","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1021\/acs.langmuir.8b03840","volume":"35","author":"T Ruks","year":"2019","unstructured":"Ruks, T. et al. Solution NMR spectroscopy with isotope-labelled cysteine (13C, 15N) reveals the surface structure of L-cysteine-coated ultrasmall gold nanoparticles (1.8 nm). Langmuir 35, 767\u2013778 (2019).","journal-title":"Langmuir"},{"key":"75125_CR33","doi-asserted-by":"publisher","first-page":"9766","DOI":"10.1038\/s41598-020-66487-8","volume":"10","author":"G Nzou","year":"2020","unstructured":"Nzou, G. et al. Multicellular 3D neurovascular unit model for assessing hypoxia and neuroinflammation induced blood-brain barrier dysfunction. Sci. Rep. 10, 9766 (2020).","journal-title":"Sci. Rep."},{"key":"75125_CR34","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3389\/fncel.2018.00236","volume":"12","author":"F Ju","year":"2018","unstructured":"Ju, F. et al. Increased BBB permeability enhances activation of microglia and exacerbates loss of dendritic spines after transient global cerebral ischemia. Front. Cell. Neurosci. 12, 236 (2018).","journal-title":"Front. Cell. Neurosci."},{"key":"75125_CR35","doi-asserted-by":"publisher","first-page":"C343","DOI":"10.1152\/ajpcell.00095.2018","volume":"315","author":"W Abdullahi","year":"2018","unstructured":"Abdullahi, W., Tripathi, D. & Ronaldson, P. T. Blood-brain barrier dysfunction in ischemic stroke: Targeting tight junctions and transporters for vascular protection. Am. J. Physiol. Cell Physiol. 315, C343\u2013C356 (2018).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"75125_CR36","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1177\/0271678X16629976","volume":"37","author":"MJ Haley","year":"2017","unstructured":"Haley, M. J. & Lawrence, C. B. The blood-brain barrier after stroke: Structural studies and the role of transcytotic vesicles. J. Cereb. Blood Flow Metab. 37, 456\u2013470 (2017).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"75125_CR37","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.xphs.2015.11.041","volume":"105","author":"E Tornabene","year":"2016","unstructured":"Tornabene, E. & Brodin, B. Stroke and drug delivery\u2014In vitro models of the ischemic blood-brain barrier. J. Pharm. Sci. 105, 398\u2013405 (2016).","journal-title":"J. Pharm. Sci."},{"key":"75125_CR38","doi-asserted-by":"publisher","first-page":"S381","DOI":"10.4103\/2152-7806.183492","volume":"7","author":"RA Tahir","year":"2016","unstructured":"Tahir, R. A. & Pabaney, A. H. Therapeutic hypothermia and ischemic stroke: A literature review. Surg. Neurol. Int. 7, S381-386 (2016).","journal-title":"Surg. Neurol. Int."},{"key":"75125_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S1474-4422(12)70039-X","volume":"11","author":"DM Hermann","year":"2012","unstructured":"Hermann, D. M. & Chopp, M. Promoting brain remodelling and plasticity for stroke recovery: Therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol. 11, 369\u2013380 (2012).","journal-title":"Lancet Neurol."},{"key":"75125_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/molecules23010009","volume":"23","author":"F D'Agata","year":"2018","unstructured":"D\u2019Agata, F. et al. Magnetic nanoparticles in the central nervous system: Targeting principles, applications and safety issues. Molecules 23, 9 (2018).","journal-title":"Molecules"},{"key":"75125_CR41","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.neuint.2017.05.011","volume":"108","author":"MA Hegazy","year":"2017","unstructured":"Hegazy, M. A. et al. Cerium oxide nanoparticles could ameliorate behavioral and neurochemical impairments in 6-hydroxydopamine induced Parkinson\u2019s disease in rats. Neurochem. Int. 108, 361\u2013371 (2017).","journal-title":"Neurochem. Int."},{"key":"75125_CR42","doi-asserted-by":"publisher","first-page":"21116","DOI":"10.1021\/acsami.7b03816","volume":"9","author":"Q Han","year":"2017","unstructured":"Han, Q. et al. Molybdenum disulfide nanoparticles as multifunctional inhibitors against Alzheimer\u2019s disease. ACS Appl. Mater. Interfaces 9, 21116\u201321123 (2017).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"75125_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.biomaterials.2017.01.006","volume":"121","author":"X Liu","year":"2017","unstructured":"Liu, X., Sui, B. & Sun, J. Blood-brain barrier dysfunction induced by silica NPs in vitro and in vivo: Involvement of oxidative stress and Rho-kinase\/JNK signaling pathways. Biomaterials 121, 64\u201382 (2017).","journal-title":"Biomaterials"},{"key":"75125_CR44","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.msec.2017.03.283","volume":"77","author":"AP Muller","year":"2017","unstructured":"Muller, A. P. et al. Gold nanoparticles prevent cognitive deficits, oxidative stress and inflammation in a rat model of sporadic dementia of Alzheimer\u2019s type. Mater. Sci. Eng. C Mater. Biol. Appl. 77, 476\u2013483 (2017).","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"75125_CR45","doi-asserted-by":"publisher","first-page":"1601666","DOI":"10.1002\/smll.201601666","volume":"13","author":"N Xiong","year":"2017","unstructured":"Xiong, N., Zhao, Y. J., Dong, X. Y., Zheng, J. & Sun, Y. Design of a molecular hybrid of dual peptide inhibitors coupled on AuNPs for enhanced inhibition of amyloid beta-protein aggregation and cytotoxicity. Small 13, 1601666 (2017).","journal-title":"Small"},{"key":"75125_CR46","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1016\/j.nano.2017.06.022","volume":"13","author":"MJ Kim","year":"2017","unstructured":"Kim, M. J., Rehman, S. U., Amin, F. U. & Kim, M. O. Enhanced neuroprotection of anthocyanin-loaded PEG-gold nanoparticles against Abeta1-42-induced neuroinflammation and neurodegeneration via the NF-KB \/JNK\/GSK3beta signaling pathway. Nanomedicine 13, 2533\u20132544 (2017).","journal-title":"Nanomedicine"},{"key":"75125_CR47","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1471-2377-9-S1-S3","volume":"9","author":"WA Banks","year":"2009","unstructured":"Banks, W. A. Characteristics of compounds that cross the blood-brain barrier. BMC Neurol. 9, S3 (2009).","journal-title":"BMC Neurol."},{"key":"75125_CR48","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.2217\/nnm.12.86","volume":"7","author":"KK Jain","year":"2012","unstructured":"Jain, K. K. Nanobiotechnology-based strategies for crossing the blood- brain barrier. Nanomedicine 7, 1225\u20131233 (2012).","journal-title":"Nanomedicine"},{"key":"75125_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-015-0133-1","volume":"13","author":"H Sela","year":"2015","unstructured":"Sela, H. et al. Spontaneous penetration of gold nanoparticles through the blood brain barrier (BBB). J. Nanobiotechnol. 13, 71 (2015).","journal-title":"J. Nanobiotechnol."},{"key":"75125_CR50","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.2217\/nnm-2017-0022","volume":"12","author":"O Betzer","year":"2017","unstructured":"Betzer, O. et al. The effect of nanoparticle size on the ability to cross the blood-brain barrier: An in vivo study. Nanomedicine 12, 1533\u20131546 (2017).","journal-title":"Nanomedicine"},{"key":"75125_CR51","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.3390\/nano5042231","volume":"5","author":"MA Busquets","year":"2015","unstructured":"Busquets, M. A., Espargar\u00f3, A., Sabat\u00e9, R. & Estelrich, J. Magnetic nanoparticles cross the blood-brain barrier: When physics rises to a challenge. Nanomaterials 5, 2231\u20132248 (2015).","journal-title":"Nanomaterials"},{"key":"75125_CR52","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1002\/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4","volume":"41","author":"VV Rostovtsev","year":"2002","unstructured":"Rostovtsev, V. V., Green, L. G., Fokin, V. V. & Sharpless, K. B. A stepwise huisgen cycloaddition process: Copper(I)-catalyzed regioselective \u201cligation\u201d of azides and terminal alkynes. Angew. Chem. Int. Ed. 41, 2596\u20132599 (2002).","journal-title":"Angew. Chem. Int. Ed."},{"key":"75125_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/acscombsci.5b00087","volume":"18","author":"V Castro","year":"2016","unstructured":"Castro, V., Rodriguez, H. & Albericio, F. CuAAC: An efficient click chemistry reaction on solid phase. ACS Combinat. Sci. 18, 1\u201314 (2016).","journal-title":"ACS Combinat. Sci."},{"key":"75125_CR54","doi-asserted-by":"publisher","first-page":"7324","DOI":"10.1039\/C4AY01203H","volume":"6","author":"H Fissan","year":"2014","unstructured":"Fissan, H., Ristig, S., Kaminski, H., Asbach, C. & Epple, M. Comparison of different characterization methods for nanoparticle dispersions before and after aerosolization. Anal. Method 6, 7324\u20137334 (2014).","journal-title":"Anal. Method"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75125-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75125-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75125-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T16:36:59Z","timestamp":1670344619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75125-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,22]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["75125"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-75125-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,22]]},"assertion":[{"value":"1 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18033"}}